流行性腎臓病における腎臓免疫複合体

A prospective radiologic and neurologic follow-up study of 61 HIV-1 -infected subjects: early beginning and slow progression of brain atrophy.

European journal of neurology·2013

Tubular differentiation in African breast cancer.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology·2009

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.

Anticancer research·2009

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2008

DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.

Oncology·2007

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Volume electron microscopy in axon regeneration research: insights into mitochondria, endoplasmic reticulum, and membrane contacts.

Frontiers in neural circuits·2026

Pharmacological activation of cGMP signaling promotes astrocyte remodeling and enrichment of perivascular GLUT1 in the murine retina.

Frontiers in cellular neuroscience·2026

Transcription factors ETV4 and ETV5 are required for nephron progenitor cell maintenance, distal nephron development and connection to the collecting system.

Frontiers in cell and developmental biology·2026

Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.

CNS & neurological disorders drug targets·2026

Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes.

Molecular neurodegeneration·2026

Multimodal magnetic resonance imaging in neuroblastoma chemotherapy: a narrative review.

World journal of surgical oncology·2026

関連する実験動画

流行性腎臓病における腎臓免疫複合体

関連する概念動画

A prospective radiologic and neurologic follow-up study of 61 HIV-1 -infected subjects: early beginning and slow progression of brain atrophy.

Tubular differentiation in African breast cancer.

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.

Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.

DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Volume electron microscopy in axon regeneration research: insights into mitochondria, endoplasmic reticulum, and membrane contacts.

Pharmacological activation of cGMP signaling promotes astrocyte remodeling and enrichment of perivascular GLUT1 in the murine retina.

Transcription factors ETV4 and ETV5 are required for nephron progenitor cell maintenance, distal nephron development and connection to the collecting system.

Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.

Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes.

Multimodal magnetic resonance imaging in neuroblastoma chemotherapy: a narrative review.

関連する実験動画

流行性腎臓病における腎臓免疫複合体

関連する概念動画

関連記事